Vascular discoloration and telangiectasia are challenging conditions that require precise treatment to avoid complications, particularly in sensitive or darker skin types. UltraClear®, the world’s first cold ablative fractional fiber laser, offers a safe and effective solution for these concerns. FDA-cleared for general skin resurfacing procedures, UltraClear® delivers controlled ablative energy to treat vascular lesions with minimal discomfort, little-to-no downtime, and high patient satisfaction.
Cold Fiber Technology for Precision
UltraClear®’s MID IR 2910 nm fiber laser operates at peak water absorption, enabling precise ablation of vascular structures without bulk heating surrounding tissue. Its fiber-optic energy delivery ensures ultra-fast, uniform pulses that minimize collateral damage, while supporting dermal remodeling through a presumed mechanism of collagen remodeling. This makes it ideal for treating telangiectasia, spider veins, and other forms of vascular discoloration safely across all skin types.
3DIntelliPulseTM for Controlled Treatment
The 3DIntelliPulseTM micro-pulsing technology allows precise modulation of energy, balancing fractional ablation with coagulation. This ensures vascular lesions are effectively targeted while minimizing discomfort and post-treatment redness. Practitioners can deliver tailored treatments, adjusting depth and coverage to address specific areas and needs without over-treating adjacent skin.
Laser-CoringTM for Targeted Vascular Remodeling
For deeper vascular lesions or stubborn telangiectasia, UltraClear®’s Laser-CoringTM mode allows controlled removal of affected tissue at depths of 1–3 mm. This precision approach combines ablation and coagulation, promoting remodeling and reducing the risk of recurrence while maintaining patient comfort and faster healing compared to traditional methods.
Applications and Patient Benefits
UltraClear® effectively treats telangiectasia, spider veins, vascular discoloration, fine lines, wrinkles, acne scars, keloids, benign cosmetic keratoses, and age spots (benign cosmetic keratoses). Its versatility allows practitioners to deliver comprehensive skin rejuvenation during the same session, optimizing both aesthetic outcomes and clinic efficiency.
Minimal Downtime and Comfort
Treatment sessions are typically 30–45 minutes, and most patients resume daily activities within 48 hours. Superficial 3DMIRACL® treatments require little-to-no topical anesthesia, while deeper Laser-CoringTM modes maintain high comfort levels. Patients experience rapid improvement in skin tone, texture, and vascular appearance, supporting long-term satisfaction and adherence to maintenance treatments.
Conclusion
UltraClear®’s advanced fiber laser technology, 3DIntelliPulseTM micro-pulsing, and Laser-CoringTM make it a powerful tool for safely and effectively treating vascular dyschromia and telangiectasia. Its ability to deliver dramatic results with minimal discomfort and rapid recovery positions it as a preferred choice for practitioners and patients seeking reliable and comprehensive skin rejuvenation.
